Last updated on February 2020

Migraine Research Study – for Acute Migraine Attack


Brief description of study

Summit Research Network is enrolling research participant volunteers in a new clinical trial for migraines. This trial will evaluate safety of an investigational study medication as well as its ability to stop an existing migraine.

Study participation will last from 4 to12 weeks and includes up to 3 visits at the research center. After a screening period of up to 8 weeks, the study medication will be administered at the research site within 1 to 6 hours the start of a qualifying migraine headache. 

Study participants will return to the research center for a final follow-up visit 4 weeks after receiving the study medication.

 

Clinical Study Identifier: TX235493

Find a site near you

Start Over

Summit Research Network, Inc.

2701 NW Vaughn Street, Suite 350 Portland, OR USA
  Connect »